Riggs Asset Managment Co. Inc. Ionis Pharmaceuticals Inc Transaction History
Riggs Asset Managment Co. Inc.
- $359 Million
- Q4 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 250 shares of IONS stock, worth $8,527. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$8,527
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
406Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$514 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$483 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$352 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$298 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$269 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.84B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...